http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2548730-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_060fafa0617bece0ef07cf8a6f61bfb3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate | 2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64d89429e8c080026b676d11f7d9313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0beef58cee9458027f95a3f3f77d3773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a5e9e68b97290bae9c7caf07a0b8e78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b634446040f668a70299670f3962d6bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e2b611da75b44b867b15b2b4f166525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2556619360c14c0c9e2fd3e9a10ad32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e38970e2f67c7c3ae5d97f87fb24c1 |
| publicationDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2548730-C2 |
| titleOfInvention | Diagnosing gluten-induced autoimmune diseases |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine, namely to diagnosing gluten-sensitive enteropathy in genetically predisposed patients, and can be used for specifying the diagnosis of autoimmune diseases. That is ensured by measuring a binding level of auto-antibodies in the patient's blood serum samples with an unchanged celiac epitope of the transglutaminase proteins as compared to a binding level of a test compound (TC). The TC represents a test antibody or its fragment, version or analogue. The TC is able to bind to the primary celiac epitope of the transglutaminase proteins. The higher binding level of the auto-antibodies with no TC added or the 50% lower binding level of the auto-antibodies with the TC added testify to a gluten-induced autoimmune disease in the above individual. n EFFECT: group of inventions provides correcting diagnosing the gluten-induced diseases and prescribing the accompanying diet with avoiding gluten sources. n 8 cl, 15 dwg, 2 tbl, 10 ex |
| priorityDate | 2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.